日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Combining site-specific gut microbiome and mycobiome profiling with clinical indicators for effective management of pediatric Crohn's disease.

将特定部位的肠道微生物组和真菌组分析与临床指标相结合，以有效管理儿童克罗恩病

期刊:iScience
影响因子:4.1
doi:10.1016/j.isci.2025.113160
Kim Dongseok, Park Seo-Young, Lee Yi Qing, Kwon Yiyoung, Choe Yon Ho, Kim Mi Jin, Lee Dong-Yup
微生物学
发表日期：2025
文献求助 收藏

Comparison of endoscopic healing and durability between combination therapy with infliximab and azathioprine versus infliximab monotherapy in pediatric Crohn's disease

比较英夫利昔单抗联合硫唑嘌呤治疗与英夫利昔单抗单药治疗在儿童克罗恩病中的内镜下愈合情况和疗效持久性

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-06445-4
Kim, Yoon Zi; Kim, Eun Sil; Kwon, Yiyoung; Kim, Seon Young; Kim, Hansol; Choe, Yon Ho; Kim, Mi Jin
克罗恩病
发表日期：2025
文献求助 收藏

Prediction of deep remission through serum TNF-α level at 1 year of treatment in pediatric Crohn's disease.

通过血清 TNF-α 水平预测儿童克罗恩病治疗 1 年后的深度缓解

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-89578-w
Kim Seon Young, Kwon Yiyoung, Kim Eun Sil, Kim Yoon Zi, Kim Hansol, Choe Yon Ho, Kim Mi Jin
其它
发表日期：2025
文献求助 收藏

Toward personalized therapeutic drug monitoring of ustekinumab in Crohn's disease: influence of previous exposure to biologics

克罗恩病患者使用乌司奴单抗进行个体化治疗药物监测：既往生物制剂暴露的影响

期刊:
影响因子:
doi:10.1177/17562848251393074
Kwon, Yiyoung; Kim, Yoon Zi; Jeong, Tae Jong; Kim, Seon Young; Kim, Hansol; Kim, Eun Sil; Choe, Yon Ho; Kim, Mi Jin
克罗恩病
发表日期：2025
文献求助 收藏

Efficacy of Combined Initial Treatment of Methotrexate with Infliximab in Pediatric Crohn's Disease: A Pilot Study

甲氨蝶呤联合英夫利昔单抗初始治疗儿童克罗恩病的疗效：一项初步研究

期刊:Biomedicines
影响因子:3.9
doi:10.3390/biomedicines11092575
Kim, Yoon-Zi; Kang, Ben; Kim, Eun-Sil; Kwon, Yiyoung; Choe, Yon-Ho; Kim, Mi-Jin
克罗恩病
发表日期：2023
文献求助 收藏

Impact of the histologic grade of acute gastrointestinal graft-versus-host disease on outcomes in pediatric patients treated with allogeneic hematopoietic stem cell transplantation

急性胃肠道移植物抗宿主病组织学分级对接受异基因造血干细胞移植治疗的儿科患者预后的影响

期刊:Frontiers in Medicine
影响因子:3
doi:10.3389/fmed.2023.1231066
Kim, Eun Sil; Kwon, Yiyoung; Choe, Yon Ho; Kim, Mi Jin; Yoo, Keon Hee
发育与干细胞
干细胞
细胞生物学
发表日期：2023
文献求助 收藏

Long-term outcomes of liver transplantation for biliary atresia and results of policy changes: over 20 years of follow-up experience

胆道闭锁肝移植的长期疗效及政策变化的影响：超过20年的随访经验

期刊:Frontiers in Pediatrics
影响因子:2
doi:10.3389/fped.2023.1242009
Kwon, Yiyoung; Ahn, Yoon Ji; Yang, Jaehun; Kim, Eun Sil; Choe, Yon Ho; Lee, Sanghoon; Kim, Mi Jin
发表日期：2023
文献求助 收藏

Free antibodies-to-infliximab are biomarker for predicting the effect of dose intensification in pediatric Crohn's disease patients with secondary loss of response

针对英夫利昔单抗的游离抗体是预测儿童克罗恩病继发性疗效丧失患者剂量强化治疗效果的生物标志物。

期刊:
影响因子:
doi:10.1177/17562848231170948
Kim, Eun Sil; Kwon, Yiyoung; Choe, Yon Ho; Kim, Mi Jin
克罗恩病
发表日期：2023
文献求助 收藏

Dual Biological Therapy for Ulcerative Colitis with Intractable Pyoderma Gangrenosum

溃疡性结肠炎合并难治性坏疽性脓皮病的双重生物疗法

期刊:
影响因子:
doi:10.5021/ad.21.060
Lee, Hae Chan; Kwon, Yiyoung; Kim, Eun Sil; Ahn, Soomin; Choe, Yon Ho; Kim, Mi Jin
结肠炎
肠炎
发表日期：2023
文献求助 收藏

Increased monocyte abundance as a marker for relapse after discontinuation of biologics in inflammatory bowel disease with deep remission

单核细胞数量增加可作为炎症性肠病深度缓解期停用生物制剂后复发的标志物

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2022.996875
Kwon, Yiyoung; Kim, Yoon Zi; Choe, Yon Ho; Kim, Mi Jin
炎症/感染
细胞生物学
炎症
单核细胞
发表日期：2022
文献求助 收藏